UM171
Chemical compound used in stem cell research
UM171 is a small molecule that has garnered significant attention in the field of hematopoietic stem cell (HSC) research due to its ability to expand these cells ex vivo. This compound has potential applications in bone marrow transplantation and regenerative medicine.
Discovery and Development
UM171 was discovered by a team of researchers at the Institute for Research in Immunology and Cancer (IRIC) at the Université de Montréal. The compound was identified through a high-throughput screening process aimed at finding molecules that could enhance the proliferation of human HSCs while maintaining their stem cell properties.
Mechanism of Action
UM171 functions by modulating the signaling pathways that regulate stem cell self-renewal and differentiation. Although the precise molecular targets of UM171 are not fully elucidated, it is known to influence the Wnt signaling pathway and other pathways critical for stem cell maintenance. This modulation allows for the expansion of HSCs without compromising their ability to differentiate into various blood cell lineages.
Applications in Medicine
The primary application of UM171 is in the field of hematopoietic stem cell transplantation. By expanding HSCs ex vivo, UM171 can potentially increase the availability of stem cells for transplantation, particularly in patients with hematological disorders such as leukemia and lymphoma. This could improve the success rates of transplants and reduce the time required for engraftment.
Clinical Trials
UM171 has been tested in clinical trials to assess its safety and efficacy in expanding HSCs for transplantation. Early results have shown promise, with patients receiving transplants of UM171-expanded cells demonstrating successful engraftment and recovery of blood cell counts.
Challenges and Future Directions
While UM171 shows great promise, there are challenges that need to be addressed before it can be widely adopted in clinical practice. These include optimizing the conditions for HSC expansion, understanding the long-term effects of UM171-expanded cells, and ensuring the scalability of the expansion process for widespread clinical use.
Future research is focused on elucidating the detailed mechanisms of UM171 action, improving the efficiency of HSC expansion, and exploring the potential of UM171 in other areas of regenerative medicine.
Related Pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD